| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/29/2009 | US7595191 Expression and purification of a recombinant Plasmodium falciparum (3D7) MSP-142; produces a highly purified protein which retains folding and disulfide bridging of the native molecule; vaccine for malaria |
| 09/29/2009 | US7595179 Recombinant reverse transcriptases |
| 09/29/2009 | US7595174 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity |
| 09/29/2009 | US7595060 Induce immunology response; vaccine that includes a dendritic cell loaded with a yeast vehicle and antigen |
| 09/29/2009 | US7595059 Diagnosis of cysticercosis; immunoassay |
| 09/29/2009 | US7595058 Chlamydia antigens and vaccine uses of the protein |
| 09/29/2009 | US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments |
| 09/29/2009 | US7595056 Andropause; coadministering luteinizing hormone (LH) and thyroid hormone (TH) to aged male rat |
| 09/29/2009 | US7595054 Fusion antigen used as vaccine |
| 09/29/2009 | US7595053 synthetic polypeptide biodrugs for treating viral disease; envelope protein, antigens, consisting of amino acid sequances from virus, more potent, protecting from T helper and B cell immunity |
| 09/29/2009 | US7595052 Composition and method for the prevention and/or the treatment of allergy |
| 09/29/2009 | US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies |
| 09/29/2009 | US7595050 Human IGM monoclonal antibody capable of inducing apoptosis in HIV-infected cells |
| 09/29/2009 | US7595049 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy |
| 09/29/2009 | US7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 |
| 09/29/2009 | US7595047 Compositions and methods for promoting or inhibiting angiogenesis |
| 09/29/2009 | US7595046 non-small cell lung, colon, colorectal, lymphoma, pancreatic or ovarian cancer |
| 09/29/2009 | US7595045 Heterodimeric integral membrane glycoprotein specific monoclonal antibody for use in treatment of cancer, inflammatory and/or autoimmune disease |
| 09/29/2009 | US7595044 Artery-and vein-specific proteins and uses therefor |
| 09/29/2009 | US7595038 Methods of treatment using antibodies to follistatin-3 |
| 09/29/2009 | CA2446741C Ophthalmic drug delivery device |
| 09/29/2009 | CA2293489C Inhibitors of dna immunostimulatory sequence activity |
| 09/29/2009 | CA2274758C Stable glassy state powder formulations |
| 09/29/2009 | CA2250118C Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/29/2009 | CA2217178C Vaccines containing a saponin and a sterol |
| 09/29/2009 | CA2194660C Growth differentiation factor-11 |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/28/2009 | CA2627903A1 Amphoteric microgels for the delivery of compounds to cells |
| 09/24/2009 | WO2009117736A2 Avian virus vaccines and uses thereof |
| 09/24/2009 | WO2009117706A2 Methods of treatment using anti-mif antibodies |
| 09/24/2009 | WO2009117640A2 Antibodies against interleukin-10 like cytokines and uses therefor |
| 09/24/2009 | WO2009117531A1 Auristatin drug linker conjugates |
| 09/24/2009 | WO2009117481A1 Use of protease-activated receptor 2 antagonists |
| 09/24/2009 | WO2009117373A2 Treatment and prevention of gardnerella vaginalis infections |
| 09/24/2009 | WO2009117310A2 Methods for treatment and prevention of mrsa/mssa |
| 09/24/2009 | WO2009117289A2 Methods for treating psoriasis |
| 09/24/2009 | WO2009117134A2 Aerosolized genetic vaccines and methods of use |
| 09/24/2009 | WO2009117116A2 Heat shock protein gp96 vaccination and methods of using same |
| 09/24/2009 | WO2009117085A1 Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 09/24/2009 | WO2009117030A2 Improved compositions for the prevention and treatment of smallpox |
| 09/24/2009 | WO2009117018A1 Inhibition of angiogenesis |
| 09/24/2009 | WO2009117011A1 Tumor cell vaccines |
| 09/24/2009 | WO2009117004A1 Reagents and methods for use in head and neck cancer diagnosis, classification and therapy |
| 09/24/2009 | WO2009116983A2 Compositions and methods for treating ebola virus infection |
| 09/24/2009 | WO2009116982A2 Pre-or post-exposure treatment for filovirus or arenavirus infection |
| 09/24/2009 | WO2009116670A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo |
| 09/24/2009 | WO2009115917A2 Improvements in preparation of influenza virus vaccine antigens |
| 09/24/2009 | WO2009115609A1 The calcium sensor STIM1 and the platelet SOC channel Orai1 (CRACM1) are essential for pathological thrombus formation |
| 09/24/2009 | WO2009115509A2 Antigenic protein fragments of streptococcus pneumoniae |
| 09/24/2009 | WO2009115508A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 09/24/2009 | WO2009090594A3 Alphavirus based vectors |
| 09/24/2009 | WO2009085269A3 Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| 09/24/2009 | WO2009082594A3 Secreted/cell bound poxvirus proteins and methods of use thereof as vaccines and anti-viral agents |
| 09/24/2009 | WO2009077577A3 Vaccine antigens from piscirickettsia salmonis |
| 09/24/2009 | WO2009061807A3 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 09/24/2009 | WO2009059298A3 Compositions and methods of enhancinc immune responses to eimeria |
| 09/24/2009 | WO2009055711A3 Anti-rsv g protein antibodies |
| 09/24/2009 | WO2009049228A3 Compositions and methods for assessing disorders |
| 09/24/2009 | WO2009049013A3 Cholera vaccines |
| 09/24/2009 | WO2009035160A8 Candidate molecule for falciparum malaria vaccine |
| 09/24/2009 | WO2008106657A3 Encapsulated amyloid-beta peptides |
| 09/24/2009 | WO2008065636A3 Treatment of disease by modulating cf5 protein |
| 09/24/2009 | WO2007116409A4 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 09/24/2009 | WO2007080308A3 Thermoreversible oil-in-water emulsion |
| 09/24/2009 | WO2004045516A9 Compositions and methods for the diagnosis and treatment of tumor |
| 09/24/2009 | US20090240038 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 09/24/2009 | US20090239926 Methods for the treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-carboxamide |
| 09/24/2009 | US20090239265 Virus like particles |
| 09/24/2009 | US20090239261 ASSEMBLY OF WILD-TYPE AND CHIMERIC INFLUENZA VIRUS-LIKE PARTICLES (VLPs) |
| 09/24/2009 | US20090239236 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/24/2009 | US20090238864 Dna vaccines encoding heat shock proteins |
| 09/24/2009 | US20090238845 Encapsulated vaccines for the oral vaccination and boostering of fish and other animals |
| 09/24/2009 | US20090238844 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 09/24/2009 | US20090238843 Recombinant mva capable of expressing structural hcv antigens |
| 09/24/2009 | US20090238842 Vaccine for preventing and treating porcine progressive atrophic rhinitis |
| 09/24/2009 | US20090238841 Hiv vaccine formulations |
| 09/24/2009 | US20090238840 Therapeutic vaccine |
| 09/24/2009 | US20090238839 Somatic Transgene Immunization and Related Methods |
| 09/24/2009 | US20090238838 Insulinotropic peptide conjugate using an immunoglobulin fc |
| 09/24/2009 | US20090238837 High Affinity Siglec Ligands |
| 09/24/2009 | US20090238836 Hip kinase for fertility control |
| 09/24/2009 | US20090238835 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238834 Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer |
| 09/24/2009 | US20090238833 Protein |
| 09/24/2009 | US20090238832 Novel compositions and method for the treatment of psoriasis |
| 09/24/2009 | US20090238831 Monoclonal antibodies and uses thereof |
| 09/24/2009 | US20090238830 Protein |
| 09/24/2009 | US20090238829 Stabilized single domain antibodies |
| 09/24/2009 | US20090238828 Combinations for the Treatment of Diseases involving Cell Proliferation |
| 09/24/2009 | US20090238827 Therapeutic use of anti-cs1 antibodies |
| 09/24/2009 | US20090238826 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage |
| 09/24/2009 | US20090238825 Novel rabbit antibody humanization methods and humanized rabbit antibodies |
| 09/24/2009 | US20090238824 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/24/2009 | US20090238823 Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| 09/24/2009 | US20090238822 Chimeric Hepatitis C Virus Antigens For Eliciting an Immune Response |
| 09/24/2009 | US20090238821 Humanized antibodies that sequester amyloid beta peptide |
| 09/24/2009 | US20090238820 ANTI-MAdCAM ANTIBODY COMPOSITIONS |
| 09/24/2009 | US20090238819 Therapeutic and diagnostic agents |
| 09/24/2009 | US20090238818 Induction of Antigen Specific Immunnologic Tolerance |
| 09/24/2009 | US20090238817 Anti-cell proliferative compounds and methods of use |